Consider Ezetimibe as a Statin Add-On

You'll continue to see LESS use of non-statins (niacin, etc) for dyslipidemia...due to limited evidence of CV benefit.

Consider discontinuing non-statins when patients are admitted if there's no good reason for the patient to be on them.

Use these tips to evaluate the need for non-statins.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals